You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 7, 2025

Quality-Controlled Sputum Analysis by Flow Cytometry
Published on: August 9, 2021
Franklin Fuda1, Mingyi Chen1, Weina Chen1
1Department of Pathology and Laboratory Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
This article examines how artificial intelligence and machine learning tools are transforming the analysis of complex cell data from flow and mass cytometry, offering improved diagnostic accuracy and reduced human error in clinical settings.
Area of Science:
Background:
No prior work has fully synthesized the integration of automated computational intelligence into routine diagnostic cellular analysis. That uncertainty drove a need to evaluate how these digital frameworks handle complex biological datasets. Prior research has shown that manual gating of high-dimensional data often suffers from subjective interpretation and operator-dependent variability. This gap motivated a comprehensive assessment of how advanced algorithms might standardize clinical workflows. Researchers have long sought methods to identify rare cell subsets that remain hidden during conventional human-led evaluation. The rapid emergence of diverse computational models now offers potential solutions for managing massive datasets. However, the practical application of these technologies in clinical environments remains fragmented across various specialized platforms. Understanding these digital tools is now a prerequisite for modern pathology and translational research efforts.
Purpose Of The Study:
The aim of this review is to evaluate the diverse types of artificial intelligence currently applied to clinical cytometry data. This work addresses the need to understand how these digital tools drive advances in diagnostic sensitivity. The authors seek to clarify the role of various algorithms in identifying cell populations and classifying samples. A primary motivation is to assist pathologists in navigating the complex landscape of available analytical software. The study explores how these technologies can be integrated into routine clinical diagnostic pipelines. By examining current progress, the authors intend to provide a roadmap for future exploratory research projects. This effort addresses the gap between emerging computational capabilities and their practical application in medical settings. The review ultimately provides a framework for clinicians to collaborate with data scientists to improve patient outcomes.
Main Methods:
The review approach involved a systematic examination of current computational strategies applied to high-dimensional cellular datasets. Authors surveyed diverse algorithmic frameworks, including both supervised and unsupervised learning models. The investigation focused on how these digital tools facilitate the identification of distinct cell populations within complex samples. Reviewers assessed various dimensionality reduction techniques used for visualizing intricate biological information. The study evaluated how these pipelines are currently deployed in both exploratory research and clinical diagnostic environments. Researchers compared the utility of open-source software against commercially available diagnostic platforms. The methodology prioritized understanding the integration of these technologies into existing laboratory workflows. This approach provided a clear overview of how data scientists and clinicians collaborate to build robust analytical systems.
Main Results:
Key findings from the literature indicate that automated tools can rapidly identify common cell populations with consistently improving accuracy. These computational models uncover patterns in high-dimensional data that human analysis frequently fails to detect. The review demonstrates that utilizing these systems reduces subjective variability across different operators and laboratory sites. Evidence shows that these approaches facilitate the discovery of rare cell subpopulations that were previously overlooked. The authors report that these technologies show significant potential to automate specific aspects of clinical diagnostic workflows. Findings suggest that supervised learning models are particularly effective for the classification of entire cytometry samples. The literature confirms that these methods improve diagnostic sensitivity by providing more objective data interpretation. These results highlight a clear trend toward the adoption of digital intelligence in modern pathology laboratories.
Conclusions:
The authors propose that integrating automated computational pipelines will enhance the precision of clinical diagnostic procedures. Synthesis and implications suggest that these digital frameworks offer a pathway to minimize subjective bias in cellular classification. Researchers indicate that adopting these technologies allows for the detection of subtle patterns within complex biological samples. The review highlights that pathologists can leverage both open-source and commercial platforms to improve their diagnostic sensitivity. Evidence suggests that collaborative efforts between clinicians and data scientists are necessary for successful implementation. The authors note that these advancements facilitate the characterization of disease states through more robust data interpretation. Future clinical workflows will likely rely on these tools to streamline the processing of high-dimensional information. This synthesis confirms that machine learning represents a transformative shift in how laboratories approach complex diagnostic tasks.
The researchers propose that these algorithms enhance diagnostic sensitivity by identifying rare cell subsets and uncovering complex patterns within high-dimensional data that remain invisible to human observers. This automated approach simultaneously reduces the subjective variability inherent in traditional manual gating techniques.
The authors discuss supervised learning for sample classification, unsupervised clustering for population identification, and various dimensionality reduction techniques. These components function as integrated pipelines that allow pathologists to visualize complex data structures more effectively than conventional methods.
The authors state that understanding these digital landscapes is necessary for pathologists to collaborate effectively with data scientists. This technical requirement ensures that clinical laboratories can successfully implement and maintain automated analysis pipelines for routine diagnostic testing.
The researchers note that these models facilitate semi-automated immune cell profiling. This data type plays a role in characterizing disease states and planning exploratory research projects, moving beyond simple population counting toward comprehensive diagnostic assessment.
The authors describe the measurement of high-dimensional data, which allows for the identification of previously undetectable cell populations. This phenomenon enables a more granular understanding of immune responses compared to standard multiparameter flow cytometry.
The researchers propose that these tools will enable pathologists to better utilize available software for disease characterization. They claim this shift will assist in breakthroughs regarding the understanding of various pathological conditions.